Cargando…
The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When
SIMPLE SUMMARY: Recent advances in treating elderly patients with chronic lymphocytic leukemia (CLL) have emphasized the importance of geriatric assessment (GA) to evaluate patient fitness and predict treatment outcomes. Targeted therapies (BTK inhibitors and venetoclax) have demonstrated significan...
Autores principales: | González-Gascón-y-Marín, Isabel, Ballesteros-Andrés, Mónica, Martínez-Flores, Sara, Rodríguez-Vicente, Ana-E, Pérez-Carretero, Claudia, Quijada-Álamo, Miguel, Rodríguez-Sánchez, Alberto, Hernández-Rivas, José-Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486487/ https://www.ncbi.nlm.nih.gov/pubmed/37686667 http://dx.doi.org/10.3390/cancers15174391 |
Ejemplares similares
-
Commentary: Five “Ws” of pulmonary arterioplasty for lung transplantation: Who, what, why, and where
por: Yeung, Jonathan C.
Publicado: (2021) -
The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
por: Pérez-Carretero, Claudia, et al.
Publicado: (2021) -
Stem Cell Therapies for Central Nervous System Trauma: The 4 Ws—What, When, Where, and Why
por: Li, Xiaofei, et al.
Publicado: (2022) -
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2021) -
The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
por: Khong, Ka-Wa, et al.
Publicado: (2022)